Evidence map›Paper›PMID 41583060›Full record

ArticleInternational journal of pharmaceutics: X2026

Data-efficient prediction in tableting using word embeddings and empirically-guided neural networks.

Najeeb Abdelrahman, Stefan Klinken-Uth

Abstract read
In one paragraph

Article in International journal of pharmaceutics: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Najeeb AbdelrahmanInstitute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Duesseldorf, Germany.
Stefan Klinken-UthInstitute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Duesseldorf, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of robust oral tablet formulations remains time-consuming, often limited by scarce data and the difficulty of incorporating categorical formulation variables into predictive models. Traditional regression methods are interpretable but struggle with nonlinear interactions, whereas modern machine learning approaches offer higher predictive power at the expense of transparency. In this study, we present a neural network framework that employs word embedding layers to represent categorical formulation factors, such as active pharmaceutical ingredients (APIs), as trainable semantic vectors. These embeddings are integrated with empirically-guided output functions and a deep ensemble strategy to predict tablet quality attributes, including tensile strength and density as well as ejection force, and dosing height, based solely on formulation composition, compression pressure, and tablet weight. The model achieved predictive accuracy comparable to or exceeding classical regression while reliably avoiding physically implausible outputs. Analysis of the learned embedding vectors revealed meaningful clustering of APIs, enabling transfer learning across materials and robust predictions even for APIs with few or no training data. Furthermore, information gain analysis demonstrated that low-concentration formulations can substantially enhance predictive accuracy, supporting more material-efficient experimental designs. These results highlight embedding-based, empirically-guided neural networks as explainable and practical tools that could accelerate pharmaceutical formulation development in the future.

Indexed as

Data-efficient modelingEmpirically-guided learningExplainable artificial intelligenceFormulation developmentTablet formulationWord embeddings

Identifiers

PMID41583060
PMCPMC12828739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.